{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:23:07Z","timestamp":1767651787989,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ajem.2011.03.019","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T10:41:07Z","timestamp":1308480067000},"page":"837.e1-837.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Single-dose ziprasidone associated with QT interval prolongation"],"prefix":"10.1016","volume":"30","author":[{"given":"Joanne C.","family":"Witsil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Zell-Kanter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark B.","family":"Mycyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2011.03.019_bb0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ajem.2008.04.020","article-title":"A systematic review of cardiovascular effects after atypical antipsychotic medication overdose","volume":"27","author":"Tan","year":"2009","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2011.03.019_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.phrs.2009.07.008","article-title":"P wave and QT changes among inpatients with schizophrenia alter parenteral ziprasidone administration","volume":"60","author":"Emul","year":"2009","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.ajem.2011.03.019_bb0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2165\/00023210-200317060-00004","article-title":"Ziprasidone in the management of schizophrenia. The QT interval issue in context","volume":"17","author":"Taylor","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajem.2011.03.019_bb0020","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/15563650701639006","article-title":"Prospective observational multi-poison center study of ziprasidone exposures","volume":"45","author":"Klein-Schwartz","year":"2007","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ajem.2011.03.019_bb0025","first-page":"1033","article-title":"Ziprasidone: a new atypical antipsychotic","volume":"6","author":"Keck","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ajem.2011.03.019_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds","volume":"1","author":"Richelson","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.ajem.2011.03.019_bb0035","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1081\/CLT-120016958","article-title":"Toxicologic myocardial sensitization","volume":"7","author":"Nelson","year":"2002","journal-title":"J Toxicol Clin Toxicol"},{"year":"2010","series-title":"Geodon [Package Insert]","key":"10.1016\/j.ajem.2011.03.019_bb0040"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675711001227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675711001227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:18:46Z","timestamp":1760023126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675711001227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0735675711001227"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2011.03.019","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-dose ziprasidone associated with QT interval prolongation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2011.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}